Investment in Bio-Medicine Exceeds 10 Billion RMB in SIP
Bio-medicine, which is one of the major industries being vigorously promoted in SIP, now boasts over 60 domestic and foreign-funded enterprises with a total investment of over 10 billion RMB. Only last year, these enterprises made sales revenue of 6.54 billion RMB and export volume of US$ 310 million, and contributed 550 million profit and tax in SIP.
Among the earliest investors in medical and pharmaceutical industry in SIP are internationally famous Siemens, Lilly Suzhou Pharmaceutical Co., Ltd., and Becton & Dickinson Medical Devices Co., Ltd., which have entered profit-making stage with yearly-growing investment returns. Then came a cluster of other pharmaceutical manufacturers of world renown such as GlaxoSmithKline, Eidai, Baxter Healthcare, Herbalife, Pfizer, Johnson & Johnson, etc. Among the top 100 pharmaceutical enterprises in terms of profit, SIP claims 5, while Beckman Coulter Instruments and Suzhou Capsugel Ltd. rank respectively the 5th and 7th in the top 50 enterprises of China’s medical materials and curatorial industry. In the medical appliances industry, BD Medical Device, Unitron hearing (Suzhou), and Siemens Hearing Instruments in SIP also occupy prominent positions.
June 24, 2007